Neoadjuvant Chemotherapy clinical trials

Explore recruiting neoadjuvant chemotherapy clinical trials.

Recruiting neoadjuvant chemotherapy studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Neoadjuvant Chemotherapy trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase III, Double-blind, Placebo controlled, Multi-center International Study of Neoadjuvant/Adjuvant Durvalumab for the Treatment of Patients with Resectable Stages II and III Non-small Cell Lung Cancer (AEGEAN).

Hungary, Poland, Austria, France, Netherlands, Italy +3 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

EORTC-1809-STBSG: A randomized phase III study of neoadjuvant chemotherapy followed by surgery versus surgery alone for patients with High Risk RetroPeritoneal Sarcoma (STRASS 2)

Denmark, Germany, Czechia, Spain, Italy, Netherlands +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

A phase III randomized trial evaluating chemotherapy followed by pelvic reirradiation versus chemotherapy alone as pre-operative treatment for locally recurrent rectal cancer (GRECCAR – PRODIGE – FRENCH) - GRECCAR 15

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Open-Label, Single Arm Phase II Trial Investigating the Efficacy, Safety and Quality of Life of Neoadjuvant Chemotherapy with Liposomal Irinotecan Combined with Oxaliplatin and 5-Fluorouracil/Folinic Acid Followed by Curative Surgical Resection in Patients with Hepatic Oligometastatic Adenocarcinoma of the Pancreas (HOLIPANC)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 3, Randomized, Double-blind Study to Evaluate Perioperative Pembrolizumab (MK-3475) + Neoadjuvant Chemotherapy versus Perioperative Placebo + Neoadjuvant Chemotherapy in Cisplatin-eligible Participants with Muscle-invasive Bladder Cancer (KEYNOTE-866)

Hungary, Belgium, Germany, Sweden, Spain, France +4 more

Therapeutic confirmatory (Phase III) EU CTIS Study details

68Ga-FAPI PET/CT: The Diagnostic Accuracy for Primary Staging and Re-staging after Chemotherapy in Patients with Gastric and Gastro-esophageal Junctional Cancer

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Neoadjuvant Chemotherapy trials by city

Neoadjuvant Chemotherapy in Toronto Neoadjuvant Chemotherapy in Vancouver Neoadjuvant Chemotherapy in Montreal Neoadjuvant Chemotherapy in Calgary Neoadjuvant Chemotherapy in Edmonton Neoadjuvant Chemotherapy in Ottawa Neoadjuvant Chemotherapy in Winnipeg Neoadjuvant Chemotherapy in Quebec City Neoadjuvant Chemotherapy in Hamilton Neoadjuvant Chemotherapy in Kitchener Neoadjuvant Chemotherapy in London Neoadjuvant Chemotherapy in Halifax Neoadjuvant Chemotherapy in New York Neoadjuvant Chemotherapy in Los Angeles Neoadjuvant Chemotherapy in Chicago Neoadjuvant Chemotherapy in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease